Extrapulmonary small cell cancer: a Canadian province's experience

…, A Sami, I Ahmad, S Yadav, R Alvi… - … Journal of the …, 2006 - Wiley Online Library
BACKGROUND. The objective of this study was to determine variables that correlate with
the survival of patients with extrapulmonary small cell carcinoma (EPSCC). METHODS. …

[HTML][HTML] Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an …

…, ME Barclay, H Abd Elkader, R Alvi… - The Lancet …, 2022 - thelancet.com
Background Greater understanding of international cancer survival differences is needed.
We aimed to identify predictors and consequences of cancer diagnosis through emergency …

Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population‐based cohort study

…, A Fields, S Chandra‐Kanthan, K Haider, R Alvi… - Cancer, 2014 - Wiley Online Library
BACKGROUND Currently, there is very low‐quality evidence available regarding benefit of
surgical resection of the primary tumor (SRPT), in patients with stage IV colorectal cancer (…

[HTML][HTML] Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple …

…, FS Vizeacoumar, S Sarker, Z Phillips, R Alvi… - Breast Cancer …, 2016 - Springer
Background CREB3L1 (cAMP-responsive element-binding protein 3-like protein 1), a member
of the unfolded protein response, has recently been identified as a metastasis suppressor …

Early discontinuation but not the timing of adjuvant therapy affects survival of patients with high-risk colorectal cancer: a population-based study

…, GF Anan, A Sami, SK Yadav, R Alvi… - Diseases of the colon …, 2010 - journals.lww.com
BACKGROUND: Adjuvant therapy results in significant improvement in survival of patients
with high-risk colorectal cancer. Little is known about the significance of timing and early …

Low‐serum GTA‐446 anti‐inflammatory fatty acid levels as a new risk factor for colon cancer

SA Ritchie, J Tonita, R Alvi, D Lehotay… - … journal of cancer, 2013 - Wiley Online Library
Gastrointestinal tract acid‐446 (GTA‐446) is a long‐chain polyunsaturated fatty acid present
in the serum. A reduction of GTA‐446 levels in colorectal cancer (CRC) patients has been …

Real-world cost-effectiveness of bevacizumab with first-line combination chemotherapy in patients with metastatic colorectal cancer: population-based retrospective …

…, W Isaranuwatchai, S Peacock, R Alvi… - MDM Policy & …, 2021 - journals.sagepub.com
Background. Real-world evidence can be a valuable tool when clinical trial data are incomplete
or uncertain. Bevacizumab was adopted as first-line therapy for metastatic colorectal …

Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and …

M Cree, J Tonita, D Turner, Z Nugent, R Alvi… - Clinical colorectal …, 2009 - Elsevier
Purpose Guideline-recommended treatment for stage II/III colorectal cancer includes postsurgical
chemotherapy and/or radiation as standard of care. This study measures adherence to …

[HTML][HTML] Mapping Canadian data assets to generate real-world evidence: lessons learned from Canadian real-world evidence for value of cancer drugs (CanREValue) …

…, C McClure, R Urquhart, JT McDonald, R Alvi… - Current …, 2022 - mdpi.com
Canadian provinces routinely collect patient-level data for administrative purposes. These
real-world data (RWD) can be used to generate real-world evidence (RWE) to inform clinical …

Twice weekly isoniazid and rifampin treatment of latent tuberculosis infection in Canadian plains Aborigines

BD McNAB, DD Marciniuk, RA Alvi, L Tan… - American journal of …, 2000 - atsjournals.org
Six months of twice weekly directly observed isoniazid and rifam-picin treatment of latent
tuberculosis (TB) infection was implemented to improve the outcome of treatment. A total of 591 …